BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36999754)

  • 21. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
    Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
    J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
    Ma Y; Zhang X; Alsaidan OA; Yang X; Sulejmani E; Zha J; Beharry Z; Huang H; Bartlett M; Lewis Z; Cai H
    Mol Cancer Res; 2021 Jan; 19(1):124-135. PubMed ID: 33077484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HCAR1/MCT1 Regulates Tumor Ferroptosis through the Lactate-Mediated AMPK-SCD1 Activity and Its Therapeutic Implications.
    Zhao Y; Li M; Yao X; Fei Y; Lin Z; Li Z; Cai K; Zhao Y; Luo Z
    Cell Rep; 2020 Dec; 33(10):108487. PubMed ID: 33296645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-chain acyl-CoA synthetase-4 regulates endometrial decidualization through a fatty acid β-oxidation pathway rather than lipid droplet accumulation.
    Zhang H; Sun Q; Dong H; Jin Z; Li M; Jin S; Zeng X; Fan J; Kong Y
    Mol Metab; 2024 Jun; 84():101953. PubMed ID: 38710444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
    Wang ME; Chen J; Lu Y; Bawcom AR; Wu J; Ou J; Asara JM; Armstrong AJ; Wang Q; Li L; Wang Y; Huang J; Chen M
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36928314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of ALOX12 by a multi-organelle-orienting photosensitizer drives ACSL4-independent cell ferroptosis.
    Wang X; Chen Y; Yang X; Cheng L; He Z; Xin Y; Huang S; Meng F; Zhang P; Luo L
    Cell Death Dis; 2022 Dec; 13(12):1040. PubMed ID: 36517470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acyl-Coenzyme A Synthetase Long-Chain Family Member 4 Is Involved in Viral Replication Organelle Formation and Facilitates Virus Replication via Ferroptosis.
    Kung YA; Chiang HJ; Li ML; Gong YN; Chiu HP; Hung CT; Huang PN; Huang SY; Wang PY; Hsu TA; Brewer G; Shih SR
    mBio; 2022 Feb; 13(1):e0271721. PubMed ID: 35038927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia-reperfusion.
    Xu Y; Li X; Cheng Y; Yang M; Wang R
    FASEB J; 2020 Dec; 34(12):16262-16275. PubMed ID: 33070393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-suppressive functions of long-chain acyl-CoA synthetase 4 in gastric cancer.
    Ye X; Zhang Y; Wang X; Li Y; Gao Y
    IUBMB Life; 2016 Apr; 68(4):320-7. PubMed ID: 26949059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy.
    Sha R; Xu Y; Yuan C; Sheng X; Wu Z; Peng J; Wang Y; Lin Y; Zhou L; Xu S; Zhang J; Yin W; Lu J
    EBioMedicine; 2021 Sep; 71():103560. PubMed ID: 34482070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-670-3p suppresses ferroptosis of human glioblastoma cells through targeting ACSL4.
    Bao C; Zhang J; Xian SY; Chen F
    Free Radic Res; 2021 Jul; 55(7):853-864. PubMed ID: 34323631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury.
    Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X
    Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD8
    Liao P; Wang W; Wang W; Kryczek I; Li X; Bian Y; Sell A; Wei S; Grove S; Johnson JK; Kennedy PD; Gijón M; Shah YM; Zou W
    Cancer Cell; 2022 Apr; 40(4):365-378.e6. PubMed ID: 35216678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial Reactive Oxygen Species Formation Determines ACSL4/LPCAT2-Mediated Ferroptosis.
    Merkel M; Goebel B; Boll M; Adhikari A; Maurer V; Steinhilber D; Culmsee C
    Antioxidants (Basel); 2023 Aug; 12(8):. PubMed ID: 37627584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion.
    Tuo QZ; Liu Y; Xiang Z; Yan HF; Zou T; Shu Y; Ding XL; Zou JJ; Xu S; Tang F; Gong YQ; Li XL; Guo YJ; Zheng ZY; Deng AP; Yang ZZ; Li WJ; Zhang ST; Ayton S; Bush AI; Xu H; Dai L; Dong B; Lei P
    Signal Transduct Target Ther; 2022 Feb; 7(1):59. PubMed ID: 35197442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNA NEAT1 regulates ferroptosis sensitivity in non-small-cell lung cancer.
    Wu H; Liu A
    J Int Med Res; 2021 Mar; 49(3):300060521996183. PubMed ID: 33730930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression.
    Grube J; Woitok MM; Mohs A; Erschfeld S; Lynen C; Trautwein C; Otto T
    Cell Death Dis; 2022 Aug; 13(8):704. PubMed ID: 35963845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance.
    Wu X; Deng F; Li Y; Daniels G; Du X; Ren Q; Wang J; Wang LH; Yang Y; Zhang V; Zhang D; Ye F; Melamed J; Monaco ME; Lee P
    Oncotarget; 2015 Dec; 6(42):44849-63. PubMed ID: 26636648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer.
    Wu X; Li Y; Wang J; Wen X; Marcus MT; Daniels G; Zhang DY; Ye F; Wang LH; Du X; Adams S; Singh B; Zavadil J; Lee P; Monaco ME
    PLoS One; 2013; 8(10):e77060. PubMed ID: 24155918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.